Most people who come to us are not at the start of their journey. They are somewhere in the middle of it, and tired.
When the medication stops working
Roughly a third of people with depression do not respond adequately to two or more antidepressants taken at an adequate dose for an adequate time. Clinically this is called treatment-resistant depression; in practice it means years of trying one drug, waiting six to eight weeks, tapering off, and starting again — each cycle carrying weight gain, sexual side effects, emotional blunting or fatigue, and each ending in the same place. The problem is not that the patient failed the treatment. It is that a medication acting on brain chemistry system-wide was never targeted at the specific circuits driving their illness.
When pain outlives its cause
People living with chronic pain are frequently told that their scans are clear and that there is nothing more to be done — as though a normal image meant the pain was not real. It is real. Pain circuits become sensitised, and the brain continues generating a pain experience long after the tissue has healed. Meanwhile the conventional path narrows towards long-term analgesics, with the dependency risk that carries, or towards surgical options that address a structure when the problem has moved into the nervous system.
When the alternative is invasive
Where medication fails, what remains on the conventional pathway is often invasive: implanted stimulators, surgical procedures, or anaesthesia-based interventions — each carrying operative risk, recovery time, cost, and the permanence of a decision that is hard to reverse. For many people these are genuinely appropriate. For many others they are simply too much, too soon, and the result is that they choose nothing at all and stay where they are.
And the cost of waiting
Between each of these steps, life continues. Work becomes harder to hold. Relationships strain under an illness nobody can see. Sleep goes, and with it the capacity to cope with everything else. The longer a condition remains untreated, the more entrenched the underlying circuits tend to become — which is precisely why the years spent cycling through options are not neutral waiting time.
Where neuromodulation fits
Non-invasive neuromodulation works at a different point entirely. Rather than flooding the whole system with a drug, or opening the body to place hardware inside it, it applies precisely targeted stimulation from outside the skull to the specific circuits involved in a condition — the prefrontal cortex in depression, the pain-processing networks in chronic pain, the regulatory circuits in anxiety.
Nothing is implanted. There is no anaesthesia, no incision, and no recovery period — patients drive themselves home and return to work the same day. Sessions last twenty to forty minutes. Side effects, where they occur at all, are typically a mild tingling at the scalp or a short-lived headache. And because it is non-invasive, it can be tried without foreclosing anything: it sits alongside the medication and the therapy a patient already has, rather than demanding they abandon what is partly working.
We are careful not to overstate this. Neuromodulation is not a cure, it does not work for everyone, and anyone who promises otherwise should be treated with suspicion. What it offers is a genuine additional option for people who were told they had run out of them — and an honest assessment of whether it is likely to help them before they commit to a course.
